Pharmaceutical composition and uses therefor

作者: Francis Herodin , Jean-Claude Mestries , Armaud Ythier , Serge Martin

DOI:

关键词:

摘要: The invention provides use of interleukin-6 in the manufacture a medicament for treatment or prophylaxis consumptive thrombohemorrhagic disorder. also dysfunction associated with reduced level at least one acute phase protein.

参考文章(13)
William C. Faquin, Mark A. Goldberg, Interleukin-6 to stimulate erythropoietin production ,(1990)
Thomas J. Podor, Jack Gauldie, Yves Guigoz, Ron Zeheb, Thomas D. Gelehrter, Jack Hirsh, Jack Hirsh, Felipe Sierra, Diane Torry, Type 1 plasminogen activator inhibitor is not an acute phase reactant in rats. Lack of IL-6- and hepatocyte-dependent synthesis. Journal of Immunology. ,vol. 150, pp. 225- 235 ,(1993)
Hideo Inoue, Makoto Kakitani, Toshifumi Mikayama, Toshihiko Kadoya, Modified HIL-6 ,(1991)
PAUL L. WOLF, The Importance of a2-Antiplasmin in the Defibrination Syndrome Archives of Internal Medicine. ,vol. 149, pp. 1724- 1725 ,(1989) , 10.1001/ARCHINTE.1989.00390080010002
Thomas Geiger, Tilo Andus, Jan Klapproth, Toshio Hirano, Tadamitsu Kishimoto, Peter C. Heinrich, Induction of rat acute-phase proteins by interleukin 6 in vivo. European Journal of Immunology. ,vol. 18, pp. 717- 721 ,(1988) , 10.1002/EJI.1830180510
José V. Castell, Maria J. Gómez-Lechón, Martina David, Toshio Hirano, Tadamitsu Kishimoto, Peter C. Heinrich, Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Letters. ,vol. 232, pp. 347- 350 ,(1988) , 10.1016/0014-5793(88)80766-X
THOMAS J. PODOR, FRANK R. JIRIK, DAVID J. LOSKUTOFF, DENNIS A. CARSON, MARTIN LOTZ, Human Endothelial Cells Produce IL-6 Annals of the New York Academy of Sciences. ,vol. 557, pp. 374- 387 ,(2008) , 10.1111/J.1749-6632.1989.TB24030.X
Tomohiro Neichi, Jun-Ichi Matsushita, Nobuo Imai, Toshiro Nagasawa, Tsukasa Abe, Pharmaceutical preparation for treatment of thrombocytopenic or platelet function-deficient disease ,(1989)